Stay updated on Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:00:28.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page footer removes the HHS Vulnerability Disclosure link and adds a new revision note, Revision: v3.3.3 (replacing the previous v3.3.2).
    Difference
    0.1%
    Check dated 2025-12-23T09:17:21.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:03:14.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Removed 'Tainan City, Taiwan' from the locations and added 'Tainan, Taiwan'.
    Difference
    0.4%
    Check dated 2025-11-17T15:00:30.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The updates are minor visual and layout adjustments to the study page with no substantive changes to core information such as eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:30:55.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    Updated version to v3.2.0 and added a government-operating-status notice; removed the prior v3.1.0 tag.
    Difference
    3%
    Check dated 2025-10-05T10:11:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial page.